Bishal Gyawali, MD, PhD, global oncologist and policy researcher, explains to me the financial toxicity faced by patients with cancer and potential strategies to mitigate it. What can be done to “avoid wisely” low-value practices?
Why do we care about physical toxicities that patients experience with cancer care and pay less attention to the impact of drug costs and financial toxicity? Bishal and I discuss it all. Must listen.